Jordan Molecular Diagnostics Market Size & Outlook
The molecular diagnostics market in Jordan is expected to reach a projected revenue of US$ 35.2 million by 2030. A compound annual growth rate of 4.8% is expected of Jordan molecular diagnostics market from 2025 to 2030.
The Jordan molecular diagnostics market generated a revenue of USD 26.0 million in 2024 and is expected to reach USD 35.2 million by 2030.
The Jordan market is expected to grow at a CAGR of 4.8% from 2025 to 2030.
In terms of segment, reagents was the largest revenue generating product in 2024.
Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Molecular diagnostics market data book summary
Market revenue in 2024
USD 26.0 million
Market revenue in 2030
USD 35.2 million
Growth rate
4.8% (CAGR from 2025 to 2030)
Largest segment
Reagents
Fastest growing segment
Reagents
Historical data
2018 - 2023
Base year
2024
Forecast period
2025 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Instruments, Reagents
Other key industry trends
In terms of revenue, Jordan accounted for 0.1% of the global molecular diagnostics market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Middle East & Africa, UAE molecular diagnostics market is projected to lead the regional market in terms of revenue in 2030.
UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 246.0 million by 2030.
The rising prevalence of infectious diseases, cancer, and genetic disorders in Jordan has led to a higher demand for precise and early-stage diagnostics. According to a report published by the Canadian Journal of Infectious Diseases and Medical Microbiology, infectious diseases, such as measles, TB, and cutaneous leishmaniasis, pose a risk for Syrian refugees and Jordan's local population. Jordan poses a serious threat of major infectious illnesses.
The impact of infectious diseases on Syria and Jordan amid the crisis is mostly due to various circumstances, including warfare and population displacement, socioeconomic progress, poverty, human susceptibility, accessibility, and healthcare quality Molecular diagnostics offer more accurate, sensitive, and rapid results compared to traditional methods, making them highly desirable for both healthcare professionals and patients.
In addition, There is a growing trend towards personalized medicine in Jordan, with an increasing focus on tailoring medical treatments based on individual genetic profiles. Molecular diagnostics play a crucial role in this trend, offering more detailed insights into genetic variations and disease susceptibility, which helps in delivering more targeted and effective treatments.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Molecular Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 68.46% in 2024.
Horizon Databook has segmented the Jordan molecular diagnostics market based on instruments, reagents covering the revenue growth of each sub-segment from 2018 to 2030.
The rising prevalence of infectious diseases, cancer, and genetic disorders in Jordan has led to a higher demand for precise and early-stage diagnostics. According to a report published by the Canadian Journal of Infectious Diseases and Medical Microbiology, infectious diseases, such as measles, TB, and cutaneous leishmaniasis, pose a risk for Syrian refugees and Jordan's local population. Jordan poses a serious threat of major infectious illnesses.
The impact of infectious diseases on Syria and Jordan amid the crisis is mostly due to various circumstances, including warfare and population displacement, socioeconomic progress, poverty, human susceptibility, accessibility, and healthcare quality Molecular diagnostics offer more accurate, sensitive, and rapid results compared to traditional methods, making them highly desirable for both healthcare professionals and patients.
In addition, There is a growing trend towards personalized medicine in Jordan, with an increasing focus on tailoring medical treatments based on individual genetic profiles. Molecular diagnostics play a crucial role in this trend, offering more detailed insights into genetic variations and disease susceptibility, which helps in delivering more targeted and effective treatments.
Jordan Molecular Diagnostics Market Product Outlook (Revenue, USD Million , 2018-2030)
Instruments
Reagents
Others Product
Jordan Molecular Diagnostics Market Test Location Outlook (Revenue, USD Million , 2018-2030)
Point of care
Self test or OTC
Central laboratories
Jordan Molecular Diagnostics Market Technology Outlook (Revenue, USD Million , 2018-2030)
PCR
ISH
INAAT
Chips and microarrays
Mass spectrometry
Sequencing
TMA
Others Technology
Jordan Molecular Diagnostics Market Application Outlook (Revenue, USD Million , 2018-2030)
Oncology
Pharmacogenomics
Infectious disease
Genetic testing
Neurological disease
Cardiovascular disease
Microbiology
Others Application
Reasons to subscribe to Molecular Diagnostics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Molecular Diagnostics Market Outlook databook
Our clientele includes a mix of Molecular Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Jordan Molecular Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Jordan Molecular Diagnostics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Jordan Molecular Diagnostics Market, 2018-2030 (US$M)